菜单

Supply Chain Intelligence about:

Lilly & Associates International

企业页面   Panama

See Lilly & Associates International's products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

以公司为组织的美国海关记录

211 U.S. shipments available for Lilly & Associates International, updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2024-01-18 Lilly & Associates International
Lilly & Associates International
XXXXXXX XXXXXXXX X XXXX
货运提单
2023-10-30 Lilly & Associates International
Ab Global Freight Forwarder Llc
X XXXXXXX XXX XXXXXXX XXXXXXX XXXXXXXXXXX XXXXXXX XXXXXX X
货运提单
2023-09-19 Lilly & Associates International
Emart America Inc.
XX XXXXXXX XXX XXXXXXX XXXXXXX XX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data

Contact information for Lilly & Associates International

 
地址
BODEGA 10DY 11D COCOSOLITO ZL COLON FREE ZONE PANAMA REP. DE PANAMA
 
 

Sample Bill of Lading

211 shipment records available

Date
2024-01-18
Shipper Name
Lilly & Associates International Sa
Shipper Address
BODEGA 10DY 11D COCOSOLITO ZL COLON FREE ZONE PANAMA REP. DE PANAMA
Consignee Name
Lilly & Associates International
Consignee Address
3401 NW 82 Avenue Suite 106 , Doral, Florida, United States, 33122
Notify Party Name
Lilly & Associates International
Notify Party Address
11440 NW 122ND ST, STE 800, MIAMI, FL 33178 USA
Weight
2149
Weight Unit
L
Weight in KG
974.77
Quantity
4
Quantity Unit
CTN
Shipment Origin
Panama
Details
974.77 kg
From port: Manzanillo, Panama
To port: Port Of Entry-Miami Seaport, Miami, Florida
Place of Receipt
Manzanillo
Foreign Port of Lading
Manzanillo, Panama
U.S. Port of Unlading
Port Of Entry-Miami Seaport, Miami, Florida
U.S. Destination Port
Port Of Entry-Miami Seaport, Miami, Florida
Commodity
XXXXXXX XXXXXXXX X XXXX
Container
SMLU3142346
Carrier Name
SEABOARD MARINE LTD
Vessel Name
HANSA HORNEBURG
Voyage Number
00053
Bill of Lading Number
SMLU7910941A006
Lloyd's Code
9373486
HTS Codes
HTS 8535.29

Recent Panjiva Research about Lilly & Associates International

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →